| Diet Quality and Coronary Artery Calcification in Adults With Heterozygous Familial Hypercholesterolemia (NCT04837638) | Laval University | 2021-07-01 |
| Genetic Testing and Motivational Counseling for FH (NCT04656028) | National Medical Research Center for Therapy and Preventive Medicine | 2020-06-15 |
| Evaluating the Efficacy of Pediatric Lipid Screening Alerts (NCT04118348) | Geisinger Clinic | 2019-10-10 |
| Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia (NCT06231459) | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 2019-01-01 |
| Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI (NCT03795038) | Fresenius Medical Care Deutschland GmbH | 2018-12-28 |
| Subclinical Atherosclerosis in Patients With Familial Hypercholesterolemia Treated With Evolocumab® (NCT04313270) | Federico II University | 2017-12-01 |
| Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry (NCT03110432) | GWT-TUD GmbH | 2017-05-18 |
| Regeneron 1331 Kinetics Sub-Study HoFH (NCT04722068) | University of Pennsylvania | 2016-10-07 |
| Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia (NCT03018678) | University of Pennsylvania | 2016-03-01 |
| Is Family Screening Improved by Genetic Testing of Familial Hypercholesterolemia (NCT04526457) | University of Pennsylvania | 2014-11-01 |
| A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158) (NCT01583647) | Merck Sharp & Dohme LLC | 2012-06-01 |
| Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter (NCT01753232) | Fresenius Medical Care Deutschland GmbH | 2012-05-01 |
| Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020) (NCT01524289) | Merck Sharp & Dohme LLC | 2012-02-03 |
| Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study (NCT01375751) | Amgen | 2011-08-02 |
| Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia (NCT00515307) | University of Tehran | 2007-06-01 |
| Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED) (NCT00384293) | Merck Sharp & Dohme LLC | 2006-09-01 |
| Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy (NCT00281008) | Kastle Therapeutics, LLC | 2006-02-01 |
| Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy (NCT00280995) | Kastle Therapeutics, LLC | 2006-01-01 |
| Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia (NCT00134485) | Pfizer | 2005-03-01 |
| Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder (NCT00134511) | Pfizer | 2005-03-01 |
| Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone. (NCT00136981) | Pfizer | 2003-12-01 |
| Hyperapo B and Coronary Heart Disease (NCT00005168) | National Heart, Lung, and Blood Institute (NHLBI) | 1984-08-01 |
| NHLBI Type II Coronary Intervention Study (NCT00000594) | National Heart, Lung, and Blood Institute (NHLBI) | 1971-11-01 |